A Registry Study of Biomarkers in Heart Valve Disease

Recruiting now

Conditions studied: Cardiovascular Diseases

In brief

Valvular Heart Disease, impacting 2.5% of the population, is predominantly observed in the elderly and is on the rise. The primary conditions within this category are Aortic Stenosis and Mitral Regurgitation. These conditions are linked to considerable morbidity and mortality, presenting a formidable challenge in optimizing treatment strategies. Pathophysiology of Valvular Heart Disease remains poorly known. The aim of the present study is to identify biomarkers involved in this disease using multi-omics approaches

Key facts

Study ID

NCT06223906

Run by

Beijing Institute of Heart, Lung and Blood Vessel Diseases

People needed

200000

Starts

2016-01-01

Expected to finish

2030-01-01

Last updated by the study team

2024-01-26

Who can join

Age: 18 and older, up to 100. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Patients clinically diagnosed with heart valve disease in Beijing Anzhen Hospital

You may not qualify if…

• Age < 18 years
• Failure to obtain medical records and ultrasound data
• Refuse follow-up

Where it is running

• Beijing Anzhen Hospital — Beijing, Beijing Municipality, China (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.